Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy

Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials